ARCHIVES

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Cancer Advocacy: March On Washington Scheduled For September 1998

October 31, 1997

Patients urge Medicare to allow an open formulary for cancer treatment.

October 15, 2004

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

Court Forces CPSC To Reopen Carcinogen Policy

January 19, 1979

Wyngaarden Helps Make Case For Facilities Funding, Reveals Plan For New NIH Building

April 15, 1988

Abortion, Miscarriage Don’t Increase Breast Cancer Risk, NCI Workshop Finds

March 7, 2003